Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine

Epilepsy is among the most common neurological chronic disorders, with a prevalence of 0.5–1%. Despite the introduction of new antiepileptic drugs during recent years, about one third of the epileptic population remain drug-resistant. Hence, especially in the pediatric population limited by differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Dini, Gianluca, Tulli, Eleonora, Dell’Isola, Giovanni Battista, Mencaroni, Elisabetta, Di Cara, Giuseppe, Striano, Pasquale, Verrotti, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164301/
https://www.ncbi.nlm.nih.gov/pubmed/35668937
http://dx.doi.org/10.3389/fphar.2022.832929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164301/
https://www.ncbi.nlm.nih.gov/pubmed/35668937
http://dx.doi.org/10.3389/fphar.2022.832929

Ejemplares similares